Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Wäsch

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Expert Opinion on Therapeutic Targets|April 12, 2011
Targeting mitotic exit for cancer treatmentRalph Wäsch
Haematologica|June 30, 2022
Plasma cell leukemia: another piece of the puzzlePellegrino Musto, Ralph Wäsch
Haematologica|November 20, 2023
In search for cure of multiple myelomaRalph Wäsch, Monika Engelhardt
Oncogene|January 8, 2005
Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cellsRalph Wäsch, Dirk Engelbert
Haematologica|March 8, 2005
Telomere length and hTERT expression in patients with acute myeloid leukemia correlate with karyotypic instabilityMonika Engelhardt, Ralph Wäsch
The Lancet. Oncology|January 15, 2023
Carfilzomib, lenalidomide, and dexamethasone maintenance for multiple myeloma: when and for whom?Monika Engelhardt, Ralph Wäsch
Nature|August 2, 2002
APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exitRalph Wäsch, Frederick R Cross
Annals of Hematology|April 3, 2025
Successful sequential application of CAR T-cell-therapies in relapsed refractory multiple myelomaPaul Mobascher, Monika Engelhardt, Ralph Wäsch
Frontiers in Genetics|July 14, 2022
The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and TherapyChristine Greil, Monika Engelhardt, Ralph Wäsch
Haematologica|December 3, 2019
Teaming up for CAR-T cell therapyRalph Wäsch, Markus Munder, Reinhard Marks
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Expert Opinion on Therapeutic Targets|April 12, 2011
Targeting mitotic exit for cancer treatmentRalph Wäsch
Haematologica|June 30, 2022
Plasma cell leukemia: another piece of the puzzlePellegrino Musto, Ralph Wäsch
Haematologica|November 20, 2023
In search for cure of multiple myelomaRalph Wäsch, Monika Engelhardt
Oncogene|January 8, 2005
Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cellsRalph Wäsch, Dirk Engelbert
Haematologica|March 8, 2005
Telomere length and hTERT expression in patients with acute myeloid leukemia correlate with karyotypic instabilityMonika Engelhardt, Ralph Wäsch
The Lancet. Oncology|January 15, 2023
Carfilzomib, lenalidomide, and dexamethasone maintenance for multiple myeloma: when and for whom?Monika Engelhardt, Ralph Wäsch
Nature|August 2, 2002
APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exitRalph Wäsch, Frederick R Cross
Annals of Hematology|April 3, 2025
Successful sequential application of CAR T-cell-therapies in relapsed refractory multiple myelomaPaul Mobascher, Monika Engelhardt, Ralph Wäsch
Frontiers in Genetics|July 14, 2022
The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and TherapyChristine Greil, Monika Engelhardt, Ralph Wäsch
Haematologica|December 3, 2019
Teaming up for CAR-T cell therapyRalph Wäsch, Markus Munder, Reinhard Marks
Pageof 18